Georgia Healthcare Group PLC GHG announces the opening of Mega Laboratory (6449K)
17 December 2018 - 6:01PM
UK Regulatory
TIDMGHG
RNS Number : 6449K
Georgia Healthcare Group PLC
17 December 2018
London, 17 December 2018
Georgia Healthcare Group PLC announces the opening of Mega
Laboratory
Georgia Healthcare Group ("GHG" or "the Group") announces the
completion of the construction of Mega Laboratory ("Mega Lab"), the
largest diagnostics laboratory in Georgia as well as in the entire
Caucasus region. Mega Lab will be formally opened today.
The multi-disciplinary laboratory, equipped with the most
up-to-date infrastructure and state-of-the-art equipment, covers
7,500 square metres. High-capacity automated systems will enable
GHG to provide accurate, high quality results for the country's
whole population. The laboratory will cover a full set of clinical
and pathology tests, some of which are being introduced in the
region for the first time.
The high technology unified laboratory will collect samples,
initially from the Group's hospitals and polyclinics throughout
Georgia. The test results will be distributed automatically to each
hospital and polyclinic within the Group, through internal
Laboratory Information Management System (LIMS), enabling us to be
significantly more efficient and provide a reliable service to our
patients. As the Group's internal demand will cover only one third
of laboratory's capacity, Mega Lab plans to develop a retail
network and to work on additional B2B contracts, contracting and
serving healthcare facilities outside the Group.
Currently, the laboratory is in the process of consolidating the
Group's internal demand and building an effective logistic system
that will be finalised within two to three months.
The project is supported by our colleagues from Jordan,
"Biolab", a subsidiary of IDH Group, who have several years of
experience in this field. Biolab is the only laboratory in the
Kingdom that has received JCI accreditation as an independent
laboratory, and will support Mega Lab to get the same accreditation
over the next few years. They are conducting training and knowledge
sharing for our personnel and are also creating an initial
technical base.
"I am very pleased to announce the completion of the
strategically important project, which will be new, separate
business line under GHG and which will bring new growth
opportunities to the Group. Mega Lab enables us to provide
high-quality laboratory and diagnostic services to the country's
population and to improve efficiency Group-wide. In addition to
covering basic laboratory tests, the new laboratory allows us to
introduce complex tests for oncology and molecular lab, some of
that have never previously been completed in Georgia and for which
blood samples had to be sent abroad. The launch is in line with our
strategy to invest in and develop new medical services to keep
filling existing service gaps in the country, supporting the
market's continuing development and our services export strategy.
Finally, I would like to thank IDH Group and each member of the
Biolab's team for their great input and continuous support during
the whole process." - commented Nikoloz Gamkrelidze, CEO of Georgia
Healthcare Group.
Name of authorised official of issuer responsible for making
notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding
company of the largest healthcare services provider in the
fast-growing, predominantly privately-owned, Georgian healthcare
services market. GHG's leadership position is underpinned by
offering the most comprehensive range of inpatient and outpatient
services targeting the mass market segment through its vertically
integrated network of 37 hospitals and 16 district polyclinics. GHG
is the single largest market participant, accounting for 25% of
total hospital bed capacity in the country, as of 30 September
2018. GHG is also the largest pharmaceuticals retailer and
wholesaler in Georgia, with approximately 30% market share by
revenue. GHG is the second largest provider of medical insurance in
Georgia with a 27% market share based on net insurance premiums
earned and approximately 158,000 insurance customers as at
September 2018. GHG employed a total of c.15,500 people as at 30
September 2018, including c.3,600 physicians and 2,900
pharmacists.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze Irakli Gogia Ketevan Kalandarishvili
CEO CFO Head of Investor
Relations
+995 322 550505
+995 322 550505 (5077) +995 322 550505 (5088) (5079)
ngamkrelidze@ghg.com.ge irakligogia@ghg.com.ge ir@ghg.com.ge
This news report is presented for general informational purposes
only and should not be construed as an offer to sell or the
solicitation of an offer to buy any securities
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFKODPABDKKBD
(END) Dow Jones Newswires
December 17, 2018 02:01 ET (07:01 GMT)
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From Apr 2024 to May 2024
Georgia Healthcare (LSE:GHG)
Historical Stock Chart
From May 2023 to May 2024